| Female Reproductive System Adenocarcinoma studied in …STUDIED_INderived200 of 454show all (up to 200) |
|---|
| → studied in | NCT02345265Phase 2 · active not recruiting Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02446600Phase 3 · active not recruiting Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Fallopian Tube Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02502266Phase 2/Phase 3 · active not recruiting Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Fallopian Tube Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03348631Phase 2 · active not recruiting Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05256225Phase 3 · recruiting Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07061977Phase 3 · recruiting Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07504588Phase 2 · recruiting Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07705035Phase 1 · recruiting DBC-664 in Adult Patients With Solid Tumors · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05112601Phase 2 · recruiting Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05956093NA · active not recruiting 68Ga-FAPI PET/CT in the Staging of High-Grade Epithelial Ovarian Cancers: A Pilot Study · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07078838Phase 2 · not yet recruiting Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03564340Phase 1/Phase 2 · recruiting Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Low-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03643510Phase 2 · completed Evaluating Cancer Response to Treatment With Abemaciclib and Fulvestrant in Women With Recurrent Endometrial Cancer · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06084780Phase 2 · not yet recruiting Intestinal & Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE) · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05276973Phase 1 · active not recruiting Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05920798Phase 1/Phase 2 · active not recruiting Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Fallopian Tube Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07832227Phase 2 · not yet recruiting Imlunestrant/Abemaciclib/Selinexor in Ovarian and Endometrial · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Ovarian Low Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07020117Phase 1 · recruiting A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04604613active not recruiting Prediction of Recurrence Among Low Risk Endometrial Cancer Patients · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07718854Phase 2 · recruiting Sacituzumab Tirumotecan +/- Pembrolizumab in I/O Exposed Metastatic or Recurrent Ovarian Clear Cell Cancer · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Ovarian Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07821879recruiting Routine Shallow-coverage Whole Genome Sequencing Testing of Liquid-based Cervical Smears for the Early Diagnosis of Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02598219Phase 3 · completed Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence. · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07429487NA · recruiting Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Ovarian Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04575935Phase 3 · recruiting Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Fallopian Tube Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07772869NA · recruiting Uterine Lavage to Detect Ovarian Cancer Risk · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Fallopian Tube High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04633239Phase 1 · recruiting Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Ovarian High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07764744NA · not yet recruiting Ovarian Cancer Liquid Biopsy for Early Assessment & Detection in Individuals With BRCA1/2 Pathogenic Variants · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Serous Tubal Intraepithelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02101775Phase 2 · active not recruiting Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Ovarian Clear Cell Cystadenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02397083Phase 2 · active not recruiting Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07812636early Phase 1 · not yet recruiting Tirzepatide and Levonorgestrel IUD Therapy for EIN and Early-Stage Endometrial Cancer · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00977574Phase 2 · active not recruiting Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02257528Phase 2 · active not recruiting Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04585958Phase 1 · recruiting Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02208375Phase 1 · active not recruiting mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01617382recruiting Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05950464Phase 1 · recruiting Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07796672recruiting Feasibility Study of Blood Biomarker Identification in Cervical Cancer · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02880007Phase 2 · completed Dose Optimization in 3D Pulsed Dose Rate Brachytherapy for Patients With Locally Advanced Cervical Cancer · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07791732Phase 3 · not yet recruiting A Study of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab as Maintenance Therapy in Second-Line Platinum-Sensitive Recurrent Ovarian Cancer (REJOICE-Ovarian03) · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01081262Phase 3 · active not recruiting Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Ovarian Mucinous Cystadenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02142803Phase 1 · active not recruiting TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02839707Phase 2/Phase 3 · active not recruiting Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Fallopian Tube High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03660826Phase 2 · active not recruiting Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07753824Phase 2 · not yet recruiting A Phase II Study of Ivonescimab Combined With Intraperitoneal Paclitaxel in Patients With High-Grade Metastatic Appendiceal Adenocarcinoma (AA) · condition mapped PROBABILISTIC · 454 trials mapped (187 active) | — | — | Mucinous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04034927Phase 2 · active not recruiting Testing the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurrent Ovarian, Fallopian Tube or Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Fallopian Tube High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05281471Phase 3 · recruiting Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076) · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07349641Phase 2 · not yet recruiting A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02068794Phase 1/Phase 2 · active not recruiting MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Fallopian Tube Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02466971Phase 3 · active not recruiting Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Vaginal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05548296Phase 2 · recruiting A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05554367Phase 2 · active not recruiting Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Ovarian Low Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06468215NA · recruiting Fertility Sparing Therapy for Patients With Stage IA G2 Endometrial Cancer · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03096054Phase 1 · completed A Phase I Trial of LY3143921 Hydrate in Solid Tumours · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05415709early Phase 1 · active not recruiting Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05463796recruiting InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Serous Tubal Intraepithelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06792552Phase 1 · recruiting A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07769346recruiting The Appendix Cancer PMP Research Foundation Natural History Study/Patient Registry · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05231122Phase 2 · recruiting Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Ovarian Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06072781Phase 3 · recruiting A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Low-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02217956Phase 1 · completed Dose Escalation of Cisplatin Hyperthermic Intraperitoneal Chemotherapy After Surgery in Patients With Unresectable Stage IIIC Ovarian, Tube or Peritoneal Primary Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Ovarian Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02978625Phase 2 · active not recruiting Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Primary Cutaneous Mucinous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06399757Phase 1/Phase 2 · active not recruiting A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03943173early Phase 1 · active not recruiting Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Fallopian Tube High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06543576Phase 1/Phase 2 · recruiting External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00488878recruiting Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Ovarian Low Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05046080recruiting Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05114421Phase 2 · active not recruiting Pembrolizumab and Lenvatinib for the Treatment of Serous Ovarian Cancer Patients · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Fallopian Tube High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06549855NA · recruiting PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04291612recruiting Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06580314Phase 3 · recruiting Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05226507Phase 1 · terminated A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Ovarian Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06188520Phase 1/Phase 2 · recruiting A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07747506Phase 2 · not yet recruiting Continued Access to Avutometinib in Combination With Defactinib in Patients With Recurrent Low-Grade Serous Ovarian Cancer (LGSOC) · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Ovarian Low Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02101788Phase 2/Phase 3 · completed Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Ovarian Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04739800Phase 2 · active not recruiting Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Fallopian Tube Mucinous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05579366Phase 1/Phase 2 · recruiting Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02595879Phase 1 · active not recruiting Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02627443Phase 1 · active not recruiting Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Ovarian High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03914612Phase 3 · active not recruiting Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04616534Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Fallopian Tube High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05538897Phase 1/Phase 2 · active not recruiting Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06856499Phase 1 · recruiting Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Ovarian Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03586661Phase 1 · completed Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06377527recruiting Establishing a Tumor Registry of Patients With Mesonephric-like Adenocarcinoma (MLA) · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Mesonephric-Like Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03120624Phase 1 · active not recruiting VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04092270Phase 1 · active not recruiting A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Endometrial High Grade Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06394804Phase 2 · recruiting A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Low-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06476808Phase 1 · recruiting A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors. · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04719273Phase 2 · completed Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04622670NA · active not recruiting Yoga Therapy During Chemotherapy and Radiation Treatment for the Improvement of Physical and Emotional Well-Being in Patients With Stage IB2-IIIB Cervical Cancer · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07398313NA · completed Effect of Prehabilitation on Recovery Outcomes in Post-Surgical Cervical Cancer Women · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01116648Phase 1/Phase 2 · active not recruiting Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Ovarian Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05057715Phase 1 · active not recruiting huCART-meso + VCN-01 in Pancreatic and Ovarian Cancer · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Ovarian Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05451849Phase 1/Phase 2 · terminated A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Ovarian Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07693452Phase 2 · recruiting Metformin in Pseudomyxoma Peritonei Secondary to Appendiceal Mucinous Neoplasms · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03587311Phase 2 · active not recruiting Bevacizumab and Anetumab Ravtansine or Paclitaxel in Treating Patients With Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01883297Phase 1 · active not recruiting "Re-Stimulated" TILs And IL-2 Therapy for Platinum Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04214067Phase 3 · active not recruiting Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07436793Phase 2 · recruiting Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01871571Phase 2 · terminated Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Rectal Mucinous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07675967recruiting Clonal Hematopoiesis Chemotherapy and Radiation Effects Study · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Ovarian Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07665684Phase 1/Phase 2 · not yet recruiting Samuraciclib in Combination With Gemcitabine/Nab-Paclitaxel in Patients With Metastatic Basal-Like Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Mucinous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05005403Phase 1 · recruiting Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06213571NA · completed Remote Home-Based Exercise Program for Strength Training in Endometrial Cancer Survivors in Rural Areas · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07503808Phase 1 · recruiting A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Appendix Mucinous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06967961NA · recruiting Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05639972Phase 1/Phase 2 · recruiting E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Human Papillomavirus-Related Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05686226Phase 2 · recruiting E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Human Papillomavirus-Related Vaginal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06494150Phase 2 · active not recruiting Nab-Sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer (NARETO) · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Ovarian Low Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04494113early Phase 1 · active not recruiting Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of Hysterectomy · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07107334Phase 2 · recruiting A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00951496Phase 3 · completed Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Fallopian Tube Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06730347Phase 2 · recruiting A Study of Lorigerlimab in Participants With Advanced Solid Tumors · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Vaginal Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07454642Phase 1 · recruiting AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Vulvar Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002968Phase 3 · completed Edrecolomab in Treating Patients With Stage II Colon Cancer · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Colon Mucinous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05039801Phase 1 · recruiting IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Ovarian Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01167712Phase 3 · active not recruiting Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03008408Phase 2 · active not recruiting A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07583329not yet recruiting Comparison of Sentinel Lymph Node Applications in Endometrial Cancer Cases Performed With Vaginal Natural Orifice Transluminal Endoscopic Surgery (V-NOTES) and Conventional Laparoscopy · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04314401active not recruiting National Cancer Institute "Cancer Moonshot Biobank" · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Ovarian High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05049538recruiting Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03713203NA · recruiting PAGETEX® Photodynamic Therapy Device for the Treatment of Extra Mammary Paget's Disease of the Vulva (EMPV). · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Vulvar Paget Disease | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06466382NA · recruiting OV Precision: Study Examining the Benefit of a Tumor- and Patient-specific Cancer Therapy · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Ovarian Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01737619NA · active not recruiting PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05440760NA · recruiting Using Virtual Reality Technology to Improve Patient Experience and Quality of Care During Brachytherapy · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05027828recruiting CtDNA as a Novel Biomarker of Treatment Efficacy in Patients With Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02874430Phase 2 · terminated Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02659241early Phase 1 · active not recruiting Adavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Fallopian Tube High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07062016recruiting Molecular and ctDNA Characterization of High-Risk Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Endometrial High Grade Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05335993Phase 2 · active not recruiting A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer. · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Ovarian Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06451497Phase 1 · recruiting This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Ovarian High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04498117Phase 3 · active not recruiting Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Ovarian Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05605535Phase 2 · active not recruiting Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Ovarian Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02122185Phase 2 · completed Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Ovarian Clear Cell Cystadenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05870761Phase 2 · active not recruiting Combination Niraparib and Dostarlimab Therapy for Recurrent or Persistent Uterine Serous Carcinoma · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07276360Phase 2 · recruiting Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04095364Phase 3 · active not recruiting Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Ovarian Low Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04919629Phase 2 · recruiting APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Fallopian Tube Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04814108Phase 2 · completed A Study of Azenosertib (ZN-c3) in Women With Recurrent or Persistent Uterine Serous Carcinoma · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05500391Phase 2 · recruiting Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Ovarian Mucinous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03875820Phase 1 · active not recruiting Phase I Trial of Defactinib and VS-6766. · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Low-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05824481Phase 2 · active not recruiting Study of Cadonilimab (AK104) Plus Lenvatinib in Patients With Advanced Endometrial Cancer · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06369155Phase 2 · recruiting Azenosertib in Uterine Serous Carcinoma: Biomarker Study · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07432594Phase 2 · not yet recruiting Neoadjuvant Aitua (PD-1/CTLA-4 Bispecific) Plus Nab-Paclitaxel and Carboplatin for Advanced High-Grade Serous Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06513065Phase 3 · recruiting Study to Evaluate the Non-inferiority of Low-dose HIPEC Versus High-dose HIPEC in the Treatment of PMP (HIPEC-PMP) · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06689956recruiting Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07226102NA · withdrawn Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic or Breast Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07378371NA · not yet recruiting Proactive Temperature Management in CRS-HIPEC for Prevention of Delirium · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05542407Phase 1 · recruiting ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04024917NA · recruiting Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07341360early Phase 1 · recruiting Pseudovax - A Cancer Vaccine for Patients With Pseudomyxoma Peritonei · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07328737NA · recruiting One vs Three HIPEC Cycles After CRS for Pseudomyxoma Peritonei · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01048853NA · terminated Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05504252Phase 2 · active not recruiting METIMMOX-2: Metastatic pMMR/MSS Colorectal Cancer - Shaping Anti-Tumor Immunity by Oxaliplatin · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Mucinous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06839378NA · completed Flura-seq for Evaluating the Effects of Different Hyperthermic Intraperitoneal Chemotherapy Regimens on the Transcriptome of Pseudomyxoma Peritonei · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00565851Phase 3 · active not recruiting Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Fallopian Tube Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06690775Phase 2 · recruiting CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer. · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Ovarian Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06682572Phase 2 · active not recruiting A Study of Avutometinib + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer in Japanese Patients · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Low-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03422198Phase 3 · recruiting Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02364713Phase 2 · terminated MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Fallopian Tube Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07269574not yet recruiting Impact of Dietary Patterns on Prognosis of Ovarian Cancer Patients During PARPi Maintenance · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07268469NA · not yet recruiting Minimal Residual Disease in Solid Malignancies · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05973487Phase 1 · active not recruiting A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Human Papillomavirus-Related Vaginal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03738228Phase 1 · completed Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05902988Phase 1/Phase 2 · recruiting A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02111941early Phase 1 · completed Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Fallopian Tube Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03325634Phase 1 · completed Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Primary Ovarian or Uterine Cancer · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05512208Phase 2 · recruiting A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04049227early Phase 1 · completed Abemaciclib and Letrozole in Treating Patients With Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04106414Phase 2 · active not recruiting Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03460483NA · completed Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06639074Phase 2 · recruiting Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Fallopian Tube High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01935934Phase 2 · completed Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06861855not yet recruiting Prognosis of METTL-14 in Endometrial Carcinoma · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04111978Phase 3 · recruiting MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO) · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Ovarian Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05329532Phase 1/Phase 2 · recruiting Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Ovarian High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04794322recruiting Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Ovarian High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05998135Phase 2 · recruiting Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Ovarian High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07153952Phase 1/Phase 2 · active not recruiting RT for Adenocarcinoma/Adenosquamous Carcinoma · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03300557Phase 2 · completed Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03907852Phase 1/Phase 2 · active not recruiting Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Ovarian High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07141186Phase 2 · not yet recruiting QL1706 in Patients With Recurrent and Metastatic Cervical Cancer Resistant to Prior PD-1/PD-L1 Antibody Therapy · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05113368Phase 2 · recruiting Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Ovarian Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03748186Phase 1 · completed Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04080284Phase 2 · completed Trial of Maintenance With Niraparib- Uterine Serous Carcinoma · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06976892Phase 1 · recruiting Investigating Idetrexed and Olaparib in Patients With Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04159155Phase 2/Phase 3 · terminated A Study of Various Treatments in Serous or p53 Abnormal Endometrial Cancer · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Ovarian Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06715592Phase 2 · active not recruiting ECT STUDY High-grade or Initially Invasive Vulva - GinOnc-ECT Study · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Vulvar Paget Disease | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07100288recruiting Anatomopathological Analysis of the Infundibulopelvic Ligament in Patients With Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Ovarian Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04458597NA · completed Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus. · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07077876recruiting Surgical and Obstetric Outcomes in Endometrial Adenocarcinoma and Atypical Endometrial Hyperplasia With Conservative Treatment · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07068178Phase 2 · not yet recruiting Evaluating the Efficacy of Hyperthermic Intraperitoneal Treatment to Enhance the Sensitivity of Immune Checkpoint Inhibitor in Patients With Advanced Ovarian Cancer： A Single-arm Study · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Ovarian Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02140021NA · terminated Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07028242not yet recruiting Ultrasound and Histology in AEH and Early EEC Treated Conservatively · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06393751Phase 1/Phase 2 · withdrawn Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian Cancer · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Fallopian Tube Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03108131Phase 2 · completed Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors · condition mapped PROBABILISTIC · 454 trials mapped (187 active) | — | — | Mucinous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02713386Phase 1/Phase 2 · completed Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 454 trials mapped (187 active) | — | — | Fallopian Tube Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01101451Phase 3 · completed Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery · condition mapped CURATED_BROADER · 454 trials mapped (187 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03201861Phase 3 · recruiting Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women · condition mapped ALIAS · 454 trials mapped (187 active) | — | — | Breast Mucinous Carcinoma | 1 | Observed | clinicaltrials | graph → |